|
| Home : CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody |
|
Mar 02
2021 |
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody |
|
SUZHOU, China, March 2, 2021 /PRNewswire/ -- Recently, CMAB Biopharma (Suzhou) Inc's ("CMAB") partner QureBio Ltd ("QureBio") has announced its innovative drug Q-1802 received United States Food and Drug Administration (FDA) clearance for an Investigational New Drug (IND) application.... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/cmab-biopharma-congratulates-qurebio-on-fda-clearance-of-ind-application-for-claudin18-2pd-l1-bispecific-antibody-301238108.html |
| |
|
Related News
|
» European Companies On 2.7 °C Warming Path, According To CDP And Oliver Wyman
» 31st Annual “Just Pray NO!” to drugs Worldwide Weekend of Prayer and Fasting
|
|
|
